Print Page | Sign In | Join
Business Wire Life Sciences News (US)
Share |

Gelesis Announces Three Presentations at Annual Endocrine Society MeetingOpen in a New Window

BOSTON--(BUSINESS WIRE)--Gelesis will deliver three poster presentations at ENDO, the Endocrine Society Annual Meeting, held in New Orleans from March 23-26.

 

Frelii Enters Strategic Agreement to Advance Cutting-edge Genomic Science and ApplicationsOpen in a New Window

LEHI, Utah--(BUSINESS WIRE)--Frelii Inc. has entered into a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Mercator Biologic and True DNA Story

 

CB Therapeutics Secures new Research and Production FacilityOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--CB Therapeutics is operating a new R&D and production facility in SoCal, accelerating its path to bringing pure therapeutic compounds to market

 

City of Hope Awarded $7.5 Million to Develop Better Treatment for a Rare, Incurable CancerOpen in a New Window

DUARTE, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CityofHope?src=hash" target="_blank"gt;#CityofHopelt;/agt;--City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma

 

Organics Announces Proposed Underwritten Public OfferingOpen in a New Window

TAMPA, Fla.--(BUSINESS WIRE)--Organics Announces Proposed Underwritten Public Offering

 

Agilent Technologies Announces Cash Dividend of 16.4 Cents per ShareOpen in a New Window

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share

 

HealthWarehouse.com Reports Full Year 2018 ResultsOpen in a New Window

CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC: HEWA) announced today that its net sales for 2018 increased 6% to $15,748,162 compared to $14,847,262 in 2017. The 2018 annual results benefited from a strong fourth quarter during which net sales increased 18% to $4,301,612 in 2018 compared to $3,632,511 during the same period in 2017. HealthWarehouse.com is a Verified Internet Pharmacy Practice Sites (VIPPS) accredited online and mail-order pharmacy authorized to sell and deliver pr

 

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Open in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to nine newly hired employees (the “Awardees”). The awards were approved by the Company’s Compensation Committee, which is comprised of independent Directors, on March 13, 2019, as an inducement material to the Awardees’ entry into employment with the Company, as permitted under NASDAQ Listin

 

Vaxart Announces Closing of Registered Direct Offering of Common StockOpen in a New Window

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the closing of its previously announced registered direct offering of 1,200,000 shares of its common stock at a price of $2.50 per share. Total gross proceeds from the offering were $3.0 million, before deducting placement agent fees and estimated offering expenses. H.C. Wainwright &

 

The American Journal of Managed Care® Announces Latest Institute for Value-Based Medicine® MeetingOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--The American Journal of Managed Care® Announces Latest Institute for Value-Based Medicine® Meeting

 

Transgene: A Positive 2018, Moving Ahead with a Strong PortfolioOpen in a New Window

STRASBOURG, France--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Transgene?src=hash" target="_blank"gt;#Transgenelt;/agt;--Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies to transform the fight against solid tumors and infectious diseases, publishes its financial results for 2018 and provides an update on its clinical and preclinical portfolio, and its technology platforms. Philippe Archinard, Chairman and Chief Executive Officer of Transgene, commented: “2018 was a year of intense activity for

 

Syngenta and the Analytics Society of INFORMS announce finalists for the 2019 Syngenta Crop Challenge in AnalyticsOpen in a New Window

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Syngenta Crop Challenge in Analytics, sponsored by INFORMS, announced finalists.

 

CWCI Study Examines the Impact of the California Workers’ Comp FormularyOpen in a New Window

OAKLAND, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CWCI?src=hash" target="_blank"gt;#CWCIlt;/agt;--CWCI found shifts in the mix of California workers' comp prescriptions and in the total drug spend after the formulary took effect.

 

MichBio Announces 7th Annual “Michigan Biosciences Day at the Capitol,” Seeks ParticipantsOpen in a New Window

ANN ARBOR, Mich. & LANSING, Mich.--(BUSINESS WIRE)--MichBio announces annual Michigan Biosciences Day at the Capitol April 10, 2019 and seeks participants.

 

Pharma Logistics Announces Partnership with PDM HealthcareOpen in a New Window

CHICAGO--(BUSINESS WIRE)--Pharma Logistics and PDM Healthcare jointly announce the offering of Pharma Logistics reverse pharmaceutical distribution services. Pharma Logistics’ services are focused on compliance, convenience and affordability, while offering insight and analytics on the pharmaceutical returns process. Founded in 1991, PDM Healthcare is a national healthcare service firm that provides group purchasing, supply chain management, business development, marketing/advertising, and educ

 

Proteintech Announces Travel Grant Winners for AACR Annual Meeting 2019Open in a New Window

CHICAGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AACR19?src=hash" target="_blank"gt;#AACR19lt;/agt;--Proteintech, the benchmark in antibodies, today announced the winners of the 2019 American Association for Cancer Research (AACR) Annual Meeting Travel Grant awards. Uday Pratap of University of Texas Health Science Center at San Antonio and Renzo Perales-Linares of the University of Pennsylvania have each been awarded $1,000 each to cover expenses to attend the 2019 Annual Meeting, being held March 29 – April 3 in Atlanta, GA. Choosing the best therapeutic strategy to

 

uLab Systems Announces Partnership with Dental Assist to Expand Commercialization of Treatment Planning Software in JapanOpen in a New Window

REDWOOD CITY, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/aligners?src=hash" target="_blank"gt;#alignerslt;/agt;--uLab Systems Announces Partnership with Dental Assist to Expand Commercialization of Treatment Planning Software in Japan

 

Swiss American CDMO, Named One of the 2019 Top 10 Contract Manufacturers in the U.S.Open in a New Window

DALLAS--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CDMO?src=hash" target="_blank"gt;#CDMOlt;/agt;--Swiss American CDMO, a Dallas-based company that specializes in skin and wound care products, was recently named one of the top 10 CDMOs.

 

axialHealthcare Announces Leadership Transitions to Support Continued GrowthOpen in a New Window

NASHVILLE, Tenn.--(BUSINESS WIRE)--axialHealthcare announces leadership transitions designed to meet the company’s increased operational needs and poise the organization for growth.

 

CORRECTING AND REPLACING DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMACOpen in a New Window

TORONTO--(BUSINESS WIRE)--DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMAC

 

Promega Joins Fight against Colorectal Cancer with $50,000 DonationOpen in a New Window

MADISON, Wis.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CRC?src=hash" target="_blank"gt;#CRClt;/agt;--Promega is donating $50,000 to colorectal cancer education during Colorectal Cancer Awareness Month and Lynch Syndrome Awareness Day (March 22).

 

CURE Media Group Adds the Prostate Cancer Foundation to Its Strategic Alliance Partnership ProgramOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CURE?src=hash" target="_blank"gt;#CURElt;/agt;--CURE Media Group Adds the Prostate Cancer Foundation to Its Strategic Alliance Partnership Program

 

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research InstituteOpen in a New Window

STERLING, Kan.--(BUSINESS WIRE)--Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient enrolled in its Phase 1 clinical trial for the oral therapeutic GZ17-6.02 received the first dose this week at HonorHealth Research Institute in Scottsdale, Ariz. Genzada’s GZ17-6.02 will be administered to patients with advanced solid cancers and lymphoma. The drug is derived in part from the black calla lily (arum palaestinum), a nat

 

Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by Floods in NebraskaOpen in a New Window

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Health will open a free 24-hour crisis line for all individuals impacted by the floods in Nebraska.

 

Oticon Introduces Opn Play, a Breakthrough in Hearing Care for ChildrenOpen in a New Window

SOMERSET, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/HearingAid?src=hash" target="_blank"gt;#HearingAidlt;/agt;--Oticon sets a new standard in child hearing care with Oticon Opn Play, a hearing aid designed to meet the developmental needs of growing children.

 

PAA to Brief Congress on Immigration & ImmigrantsOpen in a New Window

WASHINGTON--(BUSINESS WIRE)--The Population Association of America (PAA) a professional, scientific society whose members conduct research on the implications of population change, will brief Congress March 28 on new immigrants in America. The briefing, led by immigration policy experts, will take a scientific look into the peoples making the journey to our country, their background, where they come from, and share research findings regarding the U.S. immigration experience.       What: PAA Con

 

Oticon's New Opn S Hearing Aid Delivers More Control and Convenience to Individuals with Hearing LossOpen in a New Window

SOMERSET, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Hearing?src=hash" target="_blank"gt;#Hearinglt;/agt;--New Oticon Opn S hearing aids deliver more control and convenience to individuals with hearing loss.

 

Brainlab Acquires Robotics Platform Company MedineeringOpen in a New Window

MUNICH--(BUSINESS WIRE)--Brainlab, a global pioneer of software-driven medical technology, announced today the acquisition of Medineering, a developer of application-specific robotic technologies. With this move, Brainlab is driving the democratization of digital surgery with scalable solutions that expand clinical frontiers. This strategic move increases the depth of the Brainlab portfolio in cranial surgery and strengthens its offering in spinal surgery, contributing a powerful digital step i

 

Compulink Previews New User Interface for its Ophthalmology SMART EHR at Retina WorldOpen in a New Window

NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink previews new User Interface for its Ophthalmology SMART EHR at the Retina World Congress this week.

 

Washington, Michigan and Wisconsin See Flu Activity GainsOpen in a New Window

DEERFIELD, Ill.--(BUSINESS WIRE)--The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. Now in its fifth flu season, the Walgreens Flu Index was developed as a tool for consumers, health officials and the media to track flu activity in their area, and it continues to be an indicator of flu activity and important reminde

 

Fishawack continues to build best-in-class service offering with Dudnyk acquisitionOpen in a New Window

KNUTSFORD, England--(BUSINESS WIRE)--Fishawack continues to build best-in-class service offering with Dudnyk acquisition.

 

Vixiar Medical Raises $1.5 Million in Additional FinancingOpen in a New Window

BALTIMORE--(BUSINESS WIRE)--Vixiar Medical Closes Financing Round

 

Microbiome Health Index™ Platform to be Presented at Gut Microbiota for Health Summit 2019Open in a New Window

ROSEVILLE, Minn.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Cdiff?src=hash" target="_blank"gt;#Cdifflt;/agt;--Rebiotix and Ferring to highlight microbiome data from two recurrent C. diff Phase 2 clinical studies at the Gut Microbiota for Health World Summit.

 

Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug DevelopmentOpen in a New Window

LOUISVILLE, Ky.--(BUSINESS WIRE)--The ERP Biomarker Qualification Consortium was launched today by pharmaceutical industry members with the goal of qualifying event-related potential (ERP) biomarkers to aid the development of new investigational therapies for people with schizophrenia in accordance with FDA guidelines1. The Consortium, which brings together industry, academic and regulatory stakeholders, also aims to standardize ERP measurements so they are consistent across treatment centers a

 

Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare DiseasesOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases

 

Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical DevelopmentOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics appointed Alan Collis, Ph.D., and Jennifer Rocnik, Ph.D., two experts in drug discovery and development, to its leadership team.

 

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain DiseasesOpen in a New Window

LOS ANGELES--(BUSINESS WIRE)--Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases

 

American Oncology Network, LLC Simplifies Value-Based Care for Community OncologyOpen in a New Window

FORT MYERS, Fla.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AON?src=hash" target="_blank"gt;#AONlt;/agt;--American Oncology Network’s partner practices report positive results following the implementation of the network’s care management services.

 

Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated DiseasesOpen in a New Window

BOSTON & COPENHAGEN, Denmark--(BUSINESS WIRE)--Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases

 

Oncorus Announces Four Presentations at AACR Annual Meeting 2019Open in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncolytic virus therapeutics-focused company Oncorus, Inc., announces an oral presentation on ONCR-177 at the upcoming AACR 2019 annual meeting.

 

Dyve Bioscience Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019Open in a New Window

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Dyve Bioscience Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019

 

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet TherapeuticsOpen in a New Window

PARIS & NEW YORK--(BUSINESS WIRE)--Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer and Vivet will collaborate on the development of VTX-801, Vivet’s proprietary treatment for Wilson disease

 

Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® MoleculeOpen in a New Window

BOSTON & SOLNA, Sweden--(BUSINESS WIRE)--Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule

 

Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022Open in a New Window

KENILWORTH, N.J., and SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;--Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022

 

MEDIA ALERT: Renowned Healthcare Leaders Using Artificial Intelligence to Transform the Delivery of Care Featured at Pepperdine Graziadio Future of Healthcare SymposiumOpen in a New Window

LOS ANGELES--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/deepmedicine?src=hash" target="_blank"gt;#deepmedicinelt;/agt;--Pepperdine Graziadio Business School to host it 5th annual Future of Healthcare Symposium on March 21, 2019 at The Ritz-Carlton in Marina del Rey

 

Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic AsthmaOpen in a New Window

PITTSBURGH--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/asthma?src=hash" target="_blank"gt;#asthmalt;/agt;--Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet need, today announced a collaboration with a consortium of leading medical researchers in the United Kingdom to evaluate the ability of Knopp’s lead drug candidate, dexpramipexole, to reduce exacerbations in people with severe eosinophilic asthma. The project is chiefly funded by the N

 

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect